Head-to-head · free
Sabra Healthcare REIT vs Charles Schwab
SBRA vs SCHW — return on capital, cash generation, margins and balance sheet side by side.
SBRA
1 / 4
measures where SBRA leads
SCHW
3 / 4
measures where SCHW leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | SBRA · FY2025 | SCHW · FY2025 |
|---|---|---|
| Revenue | $774.6M | $23.9B |
| Net income | $155.6M | $8.9B |
| Revenue growth (yearly, multi-year) | 8.0% | 6.6% |
| Free cash flow | — | $8.8B |
| Free cash flow margin | — | 36.6% |
| Net cash / (debt) | — | — |
| ROIC | 4.8% | — |
| Return on equity | 5.6% | 20.6% |
| Gross margin | 65.0% | — |
| Operating margin | 34.1% | — |
| Net debt / EBITDA | 5.55x | — |
Figures are as reported by each company; latest fiscal year shown.
Where Sabra Healthcare REIT's cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Charles Schwab's cash went (FY2025)
- Capital spending
- $548.0M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free